MedTrace Logo

A Clinical Evaluation of the Bard® Luminexx™ Iliac Stent and Delivery System

NCT00561457 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 134

Last updated 2017-03-01

Study results available
· View outcomes & findings →

Summary

To determine the safety and effectiveness of the LUMINEXX stent for the proposed indication of treatment of common and/or external iliac artery occlusive disease

Conditions

  • Iliac Artery Occlusive Disease

Interventions

DEVICE

Bard Luminexx Iliac Stent and Delivery System

Iliac Stenting

Sponsors & Collaborators

  • C. R. Bard

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2003-06-30
Primary Completion
2008-01-31
Completion
2008-01-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00561457 on ClinicalTrials.gov